MYLAN INC., as Issuer, SOMERSET PHARMACEUTICALS, INC., as Guaranteeing Subsidiary, The GUARANTORS from time to time parties hereto and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL INDENTURE DATED as of NOVEMBER 29, 2011 TO THE INDENTURE...First Supplemental Indenture • November 30th, 2011 • Mylan Inc. • Pharmaceutical preparations • New York
First Supplemental Indenture (this “First Supplemental Indenture”), dated as of November 29, 2011, among Mylan Inc., a Pennsylvania corporation (the “Company”), Somerset Pharmaceuticals, Inc. (the “Guaranteeing Subsidiary”), a Delaware corporation and a Subsidiary of the Company, the existing Subsidiary Guarantors (as defined in the Indenture referred to herein) and The Bank of New York Mellon, as trustee under the Indenture referred to below (the “Trustee”).
MYLAN INC., as Issuer, SOMERSET PHARMACEUTICALS, INC., as Guaranteeing Subsidiary, The GUARANTORS from time to time parties hereto and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL INDENTURE DATED as of NOVEMBER 29, 2011 TO THE INDENTURE...First Supplemental Indenture • November 30th, 2011 • Mylan Inc. • Pharmaceutical preparations • New York
First Supplemental Indenture (this “First Supplemental Indenture”), dated as of November 29, 2011, among Mylan Inc., a Pennsylvania corporation (the “Company”), Somerset Pharmaceuticals, Inc. (the “Guaranteeing Subsidiary”), a Delaware corporation and a Subsidiary of the Company, the other Subsidiary Guarantors (as defined in the Indenture referred to herein) and The Bank of New York Mellon, as trustee under the Indenture referred to below (the “Trustee”).
MYLAN INC., as Issuer, SOMERSET PHARMACEUTICALS, INC., as Guaranteeing Subsidiary, The GUARANTORS from time to time parties hereto and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL INDENTURE DATED as of NOVEMBER 29, 2011 TO THE INDENTURE...Indenture • November 30th, 2011 • Mylan Inc. • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of November 29, 2011, among Mylan Inc., a Pennsylvania corporation (the “Company”), Somerset Pharmaceuticals, Inc. (the “Guaranteeing Subsidiary”), a Delaware corporation and a Subsidiary of the Company, the other Guarantors (as defined in the Indenture referred to herein) and The Bank of New York Mellon, as trustee under the Indenture referred to herein (the “Trustee”).
MYLAN INC., as Issuer, DEY, INC. DEY PHARMA, L.P. DEY LIMITED PARTNER, INC. EMD, INC. MYLAN DELAWARE INC. MYLAN LHC INC. and SOMERSET PHARMACEUTICALS, INC., as Guaranteeing Subsidiaries, The GUARANTORS from time to time parties hereto and THE BANK OF...First Supplemental Indenture • November 30th, 2011 • Mylan Inc. • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of November 29, 2011, among Mylan Inc., a Pennsylvania corporation (the “Company”), Dey, Inc., a Delaware corporation, Dey Pharma, L.P., a Delaware limited partnership, Dey Limited Partner, Inc., a Delaware corporation, EMD, Inc., a Delaware corporation, Mylan Delaware Inc., a Delaware corporation, Mylan LHC Inc., a Delaware corporation, Somerset Pharmaceuticals, Inc., a Delaware corporation (each, a Subsidiary of the Company and, together, the “Guaranteeing Subsidiaries”), the other Guarantors (as defined in the Indenture referred to herein) and The Bank of New York Mellon, as trustee under the Indenture referred to herein (the “Trustee”).
